Kura Oncology, Inc. — Form 4
Filed September 29, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 39/100
What the filing says
Chief Commercial Officer Powl Brian T. (KURA) sold 32K shares (~$345K) on the open market (19% of holdings). Open-market sale — often routine.
Why this rating
Open-market sale — often routine.
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.